Based on preclinical data using a mouse model of human pancreatic cancer, we proposed that Neu1 is a novel alternate anti-cancer target in restraining tumor neovascularization, growth, metastases, and macrophage-mediated tumorigenesis [30]. Here, NEU1 is linked to neoplasm.